Investment - Page 25

By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.’s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval for Krazati to treat

By Stephen Nakrosis Starton Therapeutics said it was terminating its business combination deal with blank-check company Healthwell Acquisition Corp. I. The deal, under which

By Adam L. Cataldo Algoma Central said a it is still trying to determine the full effects from the backlog created by a recent

By Ben Glickman Kaixin Auto said its sales fell 43% in the first half of 2023, to $18.9 million, which the company said was

Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they

One of the best near-term recession indicators is the job market. The release of October’s jobs report showed unemployment rose to 3.9%. Small increases

Molson Coors Beverage Co. posted better-than-expected earnings for the third quarter on Thursday and raised profit guidance for the full year as it continues

Palantir Technologies Inc. won itself a new fan with its latest quarterly results. HSBC analyst Stephen Bersey upgraded the stock to buy from hold